ALZHEIMERS DISEASE RESEARCH FOUNDATION: Form 990, tax year 2010
View the entire original 990 at ProPublica ↗
- Organization
- ALZHEIMERS DISEASE RESEARCH FOUNDATION (EIN 52-2396428)
- Tax period
- 2010-01-01 to 2010-12-31
- Filed
- 2011-07-02
- IRS object ID
- 201101839349300200
- Schema version
- 2010v3.2
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule C
- Schedule D
- Schedule F
- Schedule I
- Schedule J
- Schedule M
- Schedule O
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Timestamp | 2011-07-02T08:18:19-05:00 | Timestamp |
| Tax Period End Date | 2010-12-31 | TaxPeriodEndDate |
Preparer Firm PreparerFirm
Preparer Firm Business Name PreparerFirmBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | John A Epeneter PC | BusinessNameLine1 |
Preparer Firm US Address PreparerFirmUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 3 Russell Avenue | AddressLine1 |
| City | Maynard | City |
| State | MA | State |
| ZIP Code | 017541417 | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnType |
| Tax Period Begin Date | 2010-01-01 | TaxPeriodBeginDate |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 522396428 | EIN |
Name Name
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | Alzheimer's Disease Research Foundation | BusinessNameLine1 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name Control | ALZH | NameControl |
| Phone | 7812373800 | Phone |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 34 Washington Street No 200 | AddressLine1 |
| City | Wellesley | City |
| State | MA | State |
| ZIP Code | 02481 | ZIPCode |
Officer Officer
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name | Timothy W Armour | Name |
| Title | President | Title |
| Phone | 7812373800 | Phone |
| Date Signed | 2011-07-02 | DateSigned |
| Authorize Third Party | 1 | AuthorizeThirdParty |
Preparer Preparer
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name | John A Epeneter | Name |
| Phone | 9788970741 | Phone |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax Year | 2010 | TaxYear |
| Build TS | 2016-02-24 21:20:13Z | BuildTS |
Form 990 IRS990
Doing Business As DoingBusinessAs
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | Cure Alzheimer's Fund | BusinessNameLine1 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name Of Principal Officer Person | Timothy W Armour | NameOfPrincipalOfficerPerson |
Address Principal Officer US AddressPrincipalOfficerUS
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 21 Sunset Road | AddressLine1 |
| City | Weston | City |
| State | MA | State |
| ZIP Code | 02493 | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | 4575982 | GrossReceipts |
| Group Return For Affiliates | 0 | GroupReturnForAffiliates |
| Organization501c3 | X | Organization501c3 |
| Web Site | www.curealzfund.org | WebSite |
| Type Of Organization Corporation | X | TypeOfOrganizationCorporation |
| Year Formation | 2004 | YearFormation |
| State Legal Domicile | PA | StateLegalDomicile |
| Activity Or Mission Description | To fund targeted research with the highest probability of slowing, stopping or reversing Alzheimer's disease. | ActivityOrMissionDescription |
| Nbr Voting Members Governing Body | 6 | NbrVotingMembersGoverningBody |
| Nbr Independent Voting Members | 5 | NbrIndependentVotingMembers |
| Total Nbr Employees | 0 | TotalNbrEmployees |
| Total Nbr Volunteers | 0 | TotalNbrVolunteers |
| Total Gross UBI | 0 | TotalGrossUBI |
| Net Unrelated Business Txbl Income | 0 | NetUnrelatedBusinessTxblIncome |
| Contributions Grants Prior Year | 3339365 | ContributionsGrantsPriorYear |
| Contributions Grants Current Year | 3983161 | ContributionsGrantsCurrentYear |
| Program Service Revenue Prior Year | 0 | ProgramServiceRevenuePriorYear |
| Program Service Revenue CY | 0 | ProgramServiceRevenueCY |
| Investment Income Prior Year | 19523 | InvestmentIncomePriorYear |
| Investment Income Current Year | -5755 | InvestmentIncomeCurrentYear |
| Other Revenue Prior Year | 200 | OtherRevenuePriorYear |
| Other Revenue Current Year | 0 | OtherRevenueCurrentYear |
| Total Revenue Prior Year | 3359088 | TotalRevenuePriorYear |
| Total Revenue Current Year | 3977406 | TotalRevenueCurrentYear |
| Grants And Similar Amnts Prior Year | 2387914 | GrantsAndSimilarAmntsPriorYear |
| Grants And Similar Amnts CY | 3394263 | GrantsAndSimilarAmntsCY |
| Benefits Paid To Members Prior Year | 0 | BenefitsPaidToMembersPriorYear |
| Benefits Paid To Members CY | 0 | BenefitsPaidToMembersCY |
| Salaries Etc Prior Year | 320450 | SalariesEtcPriorYear |
| Salaries Etc Current Year | 305410 | SalariesEtcCurrentYear |
| Total Prof Fundrsng Exp Prior Year | 0 | TotalProfFundrsngExpPriorYear |
| Total Prof Fundrsng Exp CY | 0 | TotalProfFundrsngExpCY |
| Total Fundrsng Exp Current Year | 237914 | TotalFundrsngExpCurrentYear |
| Other Expense Prior Year | 352099 | OtherExpensePriorYear |
| Other Expenses Current Year | 382718 | OtherExpensesCurrentYear |
| Total Expenses Prior Year | 3060463 | TotalExpensesPriorYear |
| Total Expenses Current Year | 4082391 | TotalExpensesCurrentYear |
| Revenues Less Expenses Prior Year | 298625 | RevenuesLessExpensesPriorYear |
| Revenues Less Expenses CY | -104985 | RevenuesLessExpensesCY |
| Total Assets BOY | 3093146 | TotalAssetsBOY |
| Total Assets EOY | 3273140 | TotalAssetsEOY |
| Total Liabilities BOY | 34502 | TotalLiabilitiesBOY |
| Total Liabilities EOY | 318937 | TotalLiabilitiesEOY |
| Net Assets Or Fund Balances BOY | 3058644 | NetAssetsOrFundBalancesBOY |
| Net Assets Or Fund Balances EOY | 2954203 | NetAssetsOrFundBalancesEOY |
| Info In Schedule O Part III | X | InfoInScheduleOPartIII |
| Mission Description | To fund targeted research with the highest probability of slowing, stopping or reversing Alzheimer's disease. | MissionDescription |
| Significant New Program Services | 0 | SignificantNewProgramServices |
| Significant Change | 0 | SignificantChange |
| Expense | 1200000 | Expense |
| Description | In 2010 Cure Alzheimer's Fund distributed $3,094,287 for research support projects. To read a more detailed report on our research see Cure Alzheimer's Fund's Scientific Report 2010.The Alzheimer's Genome Project, Massachusetts General Hospital, Dr. Rudy TanziThe Alzheimer's Genome Project is Cure Alzheimer's Fund core research effort. It has the objective of identifying all relevant Alzheimer's genes that have not yet been discovered, thereby identifying more targets for the development of therapeutic interventions. It is the largest family-based genome scan ever of a single disease. A milestone for this project was achieved in 2008 with the identification of new genes that confer risk for or protection against Alzheimer's. This accomplishment was recognized by TIME magazine and CNN as one of the top ten medical breakthroughs of the year.Prior to this project, there were 4 known Alzheimer's genes. Now CAF researchers have identified more than 120 candidate genes and have already confirmed the mechanisms of action of several of these, thereby readying them for drug discovery. Twenty five of the most important of the genes are undergoing detailed translational analysis.This effort represents some of the most important Alzheimer's breakthroughs in recent hisotry, as the genes will greatly faciliatate the development of effective therapies for the disease. Each newly identified gene offers fresh understanding of the pathology of the disease and holds promise for the development of therapeutic intervention. | Description |
Activity2 Activity2
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | 300000 | Expense |
| Description | Abeta as an Anti-Microbial Agent; Rob Moir and Dr. Rudy Tanzi, Massachusetts General HospitalThis project explores a completely new and potentially very significant theory concerning the cause of Alzheimer's disease. The "Anti-Microbial Hypothesis" theorizes that Abeta has a positive function - protecting the brain from invading microbes and defending against bacteria. Initially this project was exclusively funded by CAF, but the subject is now also funded by a multi-million dollar grant from the National Insitutes of Health. | Description |
Activity3 Activity3
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | 100000 | Expense |
| Description | Exploring mechanisms of neuroserpin regulation in Alzheimer's disease, University of Colorado, Nicholas SeedsOur recent studies have shown that the protease inhibitor neuroserpin, which ultimately leads to decreased breakdown of amyloid-beta and its accumulation, is 70% higher in the Alzheimer's Disease brain as compared to normal brain. We've also shown that deletion of the neuroserpin gene in an Alzheimer disease model mouse, restores normal cognitive behavior. Therefore, we will study why neuroserpin is up-regulated in Alzheimer's Disease, and will screen for small molecules that block neuroserpin action and may be useful therapeutic agents to prevent amyloid accumulation and cognitive loss in Alzheimer's Disease patients. | Description |
Activity Other ActivityOther (13 entries)
| ExpenseExpense | DescriptionDescription |
|---|---|
| 400000 | Curcumin Collaborative Project, University of Pittsburgh and Massachusetts General Hospital, Dr. William Klunk and Dr. Rudy Tanzi.This collaborative project will identify and characterize novel curcumin-like derivatives for the treatment and prevention of Alzheimer's disease. The purpose of the study is to develop means of overcoming obstacles to rapid breakdown and creating methodologies for precisely delivering curcumin derivatives to appropriate locations within the brain. |
| 100000 | Brain Structure, Abeta Metabolism and Beehavior in Mice Deficient in Diabetes and Alzheimer's Associated SorCS1, Mount Sinai School of Medicine, Dr. Sam Gandy.Within the past five years, late onset Alzheimer's Disease and Type 2 Diabetes have been independently linked with the gene for a protein called SorCS1. This project's objective is to build on this early data to first better understand the link between AD and T2D, and second to point to new potential drug targets for treating both AD and T2D. |
| 496502 | Program service costs, such as an allocated portion of program salaries, fringe benefits, information and awareness, SAB/RC support, and similar direct program costs that have not been specifically allocated to the amounts of specific grant expenditures. |
| 100000 | Modulation of Abeta Deposition by Cell-Specific Mechanisms, University of Chicago, Dr. Sangram Sisodia.This project will employ a genetic strategy that allows for spatial-, temporal-, and cell-specific excision of a mutant PS transgene in order to examine cell autonomous versus non-cell-autonomous mechanisms of Abeta deposition. Researchers have strong preliminary studies to validate that the cre excision strategy works efficiently in mice and have the requisite cellular, biochemical and molecular tools to carry out the proposed studies. If specific cell types in the brain are shown to have an impact on Abeta deposition, investigations will expand to identify the cellular factor(s) responsible for the observed effects with the notion that strategies aimed at modulating the function of these molecules will be therapeutically efficacious in patients with AD. |
| 250000 | Novel Soluable Gamma-Secretase Modulators, Steven Wagner and Rudy Tanzi, University of California, San Diego and Massachusetts General Hospital.Building on in vitro characterization of a novel series of soluable gamma-secretase modulators (SGSMs) funded by Cure Alzheimer's Fund, the current project is a thorough pharmacological or in vivo examination of these molecules to identify the best or "lead" drug candidate. |
| 100000 | Passive Tau Immunotherapy for Treatment of Alzheimer's Disease, University of Pennsylvania, Dr. Virginia Lee.We propose a series of studies to rationally select candidate monoclonal antibodies (mAbs) that bind and neutralize transmissible misfolded tau species, with confirmatory testing of selected mAbs in a mouse model of pathological tau transmission. One or more selected mAbs will subsequently be tested in the established PS19 Tau transgenic (Tg) mouse model12, which develops forebrain tau inclusions, neuron loss and cognitive deficits13, to determine whether passive immunization results in an attenuation of tau-mediated neuropathology. |
| 63851 | Mouse Model for Non-Generic Alzheimer's Disease, University of California, San Digeo, Dr. Frank La Feria.The SAMP8 mouse model line is a model of accelerated senescence, and interestingly, develops sparse amyloid plaques, which is remarkable given the less amyloidogeneic properties of murine Ab. Hence, the research hypothesis for this project is that by introducing the more amyloidogenic human APP at the endogenous locus, researchers will be able to more robustly minic the onset of sporadic Alzheimer's disease, and thereby utilize this model for pre-clinical development and for widespread distribution to other investigators in the field. |
| 100000 | NMDA Receptors, University of California, San Diego, Roberto Malinow.The traditional signaling induced by NMDA-Rs is triggered by the Ca2+ ions that pass through the NMDA-R cannel. However, preliminary data indicate that blockers at the NR2B subunit, but not the NR1 subunit or the channel of the NMDA receptor prevent the synaptic effects of the NMDA receptor. These findings suggest that A-beta employs novel, non-ion flux NMDA-R signaling mechanisms to produce synaptic depression. These results may open up a new group of potential therapeutic targets for treatment of Alzheimer's disease. |
| 100000 | Anti-APOE Antibodies, Washington University, St. Louis, David Holtzman.In this project, the researchers hypothesize that targetng apoE, a component of amyloid plaques, can result in less Ab aggregation in the brain and decreased Ab-related pathology and that this treatment will have fewer side effects than the use of anti-Ab antibodies. The project will test this hypothesis in this proposal in the context of human apoE isoforms. |
| 122336 | Sustaining Support for the AlzGene, Max Planck Institute for Molecular Genetics, Lars Bertram.The AlzGene database is a revolutionary resource for Alzheimer's researchers providing data and meta-analyses from hundreds of genetic association studies in an easy-to-use, searchable, web-based database. This site allows researchers to post their findings and comment on other findings. It aggregates huge amounts of information that will help in the search for the genetic makeup of Alzheimer's. Currently, the database has more than 1,000 studies. The site also contains a continuously updated list displaying the genes most strongly associated with AD (on the website see "Top AlzGene Results"). Scientists interested in a particular gene can search for it in AlzGene to see what previous studies have reported, receiving a wealth of information in a very short amount of time. |
| 40000 | Peek and Treat Approach to Diagnosis, Treatment and Monitoring of Alzheimer's Disease, University Texas Health Science Center at Houston and University of Houston, Ananth Annapragada and Jason Eriksen.The objective of this project is to develop a nanotechnology platform that can simultaneously be used to diagnose and treat Alzheimer's. The work will explore how to develop multifunctional nanocarriers that contain both an imaging agent and a therpeutic agent and also will improve the binding capabilities of the nanocarrier allowing regulation of the release of therapeutic molecules to amyloid lesions. |
| 100000 | Design and Development of Novel ACAT Inhibitors for Alzheimer's Disease; Dora M. Kovacs, Massachusetts General Hospital.The third part of a study focusing on enzyme inhibitors that prevent or decrease the production of Abeta in the brain. This research explores the effectiveness of a drug approved for other uses. |
| 18100 | Microdialysis Supplement |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Of Other Program Service Exp | 1990789 | TotalOfOtherProgramServiceExp |
| Total Program Service Expense | 3590789 | TotalProgramServiceExpense |
| Described In501 C3 | 1 | DescribedIn501C3 |
| Schedule B Required | 1 | ScheduleBRequired |
| Political Activities | 0 | PoliticalActivities |
| Lobbying Activities | 1 | LobbyingActivities |
| Subject To Proxy Tax | 0 | SubjectToProxyTax |
| Donor Advised Funds | 0 | DonorAdvisedFunds |
| Conservation Easements | 0 | ConservationEasements |
| Collections Of Art | 0 | CollectionsOfArt |
| Credit Counseling | 0 | CreditCounseling |
| Term Or Permanent Endowments | 0 | TermOrPermanentEndowments |
| Report Land Bldg Equip | 1 | ReportLandBldgEquip |
| Report Invest Oth Securities | 0 | ReportInvestOthSecurities |
| Report Prog Rel Invest | 0 | ReportProgRelInvest |
| Report Other Assets | 0 | ReportOtherAssets |
| Report Other Liabilities | 0 | ReportOtherLiabilities |
| Report Fin48 Footnote | 0 | ReportFin48Footnote |
| Independent Audit Financial Stmt | 1 | IndependentAuditFinancialStmt |
| Consolidated Audit Financial Stmt | 0 | ConsolidatedAuditFinancialStmt |
| School | 0 | School |
| Foreign Office | 0 | ForeignOffice |
| Foreign Activities | 0 | ForeignActivities |
| More Than5000 K To Organizations | 0 | MoreThan5000KToOrganizations |
| More Than5000 K To Individuals | 1 | MoreThan5000KToIndividuals |
| Professional Fundraising | 0 | ProfessionalFundraising |
| Fundraising Activities | 0 | FundraisingActivities |
| Gaming | 0 | Gaming |
| Hospital | 0 | Hospital |
| Grants To Organizations | 1 | GrantsToOrganizations |
| Grants To Individuals | 0 | GrantsToIndividuals |
| Schedule J Required | 1 | ScheduleJRequired |
| Tax Exempt Bonds | 0 | TaxExemptBonds |
| Excess Benefit Transaction | 0 | ExcessBenefitTransaction |
| Prior Excess Benefit Transaction | 0 | PriorExcessBenefitTransaction |
| Loan To Officer Or DQP | 0 | LoanToOfficerOrDQP |
| Grant To Related Person | 0 | GrantToRelatedPerson |
| Bsnss Rltnshp With Organization | 0 | BsnssRltnshpWithOrganization |
| Bsnss Rltnshp Thru Family Member | 0 | BsnssRltnshpThruFamilyMember |
| Officer Entity With Bsnss Rltnshp | 0 | OfficerEntityWithBsnssRltnshp |
| Deductible Non Cash Contributions | 1 | DeductibleNonCashContributions |
| Deductible Contributions Of Art | 0 | DeductibleContributionsOfArt |
| Terminated | 0 | Terminated |
| Partial Liquidation | 0 | PartialLiquidation |
| Disregarded Entity | 0 | DisregardedEntity |
| Related Entity | 0 | RelatedEntity |
| Related Org Controlled Entity | 0 | RelatedOrgControlledEntity |
| Transaction Related Entity | 0 | TransactionRelatedEntity |
| Transfers To Exempt Non Chrtbl Org | 0 | TransfersToExemptNonChrtblOrg |
| Activities Conducted Partnership | 0 | ActivitiesConductedPartnership |
| Schedule O Required | 1 | ScheduleORequired |
| Number Forms Transmitted With1096 | 0 | NumberFormsTransmittedWith1096 |
| Number W2 G Included | 0 | NumberW2GIncluded |
| Number Of Employees | 0 | NumberOfEmployees |
| Unrelated Business Income | 0 | UnrelatedBusinessIncome |
| Foreign Financial Account | 0 | ForeignFinancialAccount |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTrans |
| Taxable Party Notification | 0 | TaxablePartyNotification |
| Non Deductible Contributions | 0 | NonDeductibleContributions |
| Quid Pro Quo Contributions | 0 | QuidProQuoContributions |
| Form8282 Property Disposed Of | 0 | Form8282PropertyDisposedOf |
| Indoor Tanning Services | 0 | IndoorTanningServices |
| Info In Schedule O Part VI | X | InfoInScheduleOPartVI |
| Nbr Voting Governing Body Members | 6 | NbrVotingGoverningBodyMembers |
| Number Independent Voting Members | 5 | NumberIndependentVotingMembers |
| Family Or Business Relationship | 1 | FamilyOrBusinessRelationship |
| Delegation Of Management Duties | 0 | DelegationOfManagementDuties |
| Changes To Organizing Docs | 0 | ChangesToOrganizingDocs |
| Material Diversion Or Misuse | 0 | MaterialDiversionOrMisuse |
| Members Or Stockholders | 0 | MembersOrStockholders |
| Election Of Board Members | 0 | ElectionOfBoardMembers |
| Decisions Subject To Approval | 0 | DecisionsSubjectToApproval |
| Minutes Of Governing Body | 1 | MinutesOfGoverningBody |
| Minutes Of Committees | 1 | MinutesOfCommittees |
| Officer Mailing Address | 0 | OfficerMailingAddress |
| Local Chapters | 0 | LocalChapters |
| Form990 Provided To Governing Body | 0 | Form990ProvidedToGoverningBody |
| Conflict Of Interest Policy | 1 | ConflictOfInterestPolicy |
| Annual Disclosure Covered Persons | 1 | AnnualDisclosureCoveredPersons |
| Regular Monitoring Enforcement | 1 | RegularMonitoringEnforcement |
| Whistleblower Policy | 1 | WhistleblowerPolicy |
| Document Retention Policy | 1 | DocumentRetentionPolicy |
| Compensation Process CEO | 1 | CompensationProcessCEO |
| Compensation Process Other | 1 | CompensationProcessOther |
| Investment In Joint Venture | 0 | InvestmentInJointVenture |
| States Where Copy Of Return Is Filed | MA | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | AL | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | AK | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | AS | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | AZ | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | AR | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | CA | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | CO | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | CT | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | DE | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | DC | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | FM | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | FL | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | GA | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | GU | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | HI | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | ID | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | IL | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | IN | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | IA | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | KS | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | KY | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | LA | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | ME | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | MH | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | MD | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | MI | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | MN | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | MS | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | MO | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | MT | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | NE | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | NV | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | NH | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | NJ | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | NM | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | NY | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | NC | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | ND | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | MP | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | OH | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | OK | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | OR | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | PW | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | PA | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | PR | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | RI | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | SC | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | SD | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | TN | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | TX | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | UT | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | VT | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | VI | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | VA | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | WA | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | WV | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | WI | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | WY | StatesWhereCopyOfReturnIsFiled |
| Own Website | X | OwnWebsite |
| Upon Request | X | UponRequest |
The Books Are In Care Of TheBooksAreInCareOf
Name Business NameBusiness
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | Tim Armour | BusinessNameLine1 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Telephone Number | 7812373800 | TelephoneNumber |
Address US AddressUS
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | c/o 34 Washington St | AddressLine1 |
| City | Wellesley | City |
| State | MA | State |
| ZIP Code | 02481 | ZIPCode |
Form990 Part VII Section A Form990PartVIISectionA (7 entries)
| TitleTitle | Average Hours Per WeekAverageHoursPerWeek | Individual Trustee Or DirectorIndividualTrusteeOrDirector | Reportable Comp From OrganizationReportableCompFromOrganization | Reportable Comp From Related OrgsReportableCompFromRelatedOrgs | Other CompensationOtherCompensation | OfficerOfficer | Key EmployeeKeyEmployee | Highest Compensated EmployeeHighestCompensatedEmployee |
|---|---|---|---|---|---|---|---|---|
| Jeffrey Morby | ||||||||
| Chairman of the Board | 10.00 | X | 0 | 0 | 0 | |||
| Jacqueline Morby | ||||||||
| Director | 2.00 | X | 0 | 0 | 0 | |||
| Henry McCance | ||||||||
| Director | 5.00 | X | 0 | 0 | 0 | |||
| Phyllis Rappaport | ||||||||
| Director | 1.00 | X | 0 | 0 | 0 | |||
| John S Lazo PhD | ||||||||
| Director | 1.00 | X | 0 | 0 | 0 | |||
| Timothy W Armour | ||||||||
| President | 40.00 | 177053 | 0 | 0 | X | X | X | |
| Katherine F Cutler | ||||||||
| Secretary | 30.00 | 78112 | 0 | 0 | X | |||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | 255165 | TotalReportableCompFromOrg |
| Total Reportable Comp Frm Rltd Orgs | 0 | TotalReportableCompFrmRltdOrgs |
| Total Other Compensation | 0 | TotalOtherCompensation |
| Number Individuals GT100 K | 1 | NumberIndividualsGT100K |
| Formers Listed | 0 | FormersListed |
| Total Comp GT150 K | 1 | TotalCompGT150K |
| Compensation From Other Sources | 0 | CompensationFromOtherSources |
| Number Of Contractors GT100 K | 0 | NumberOfContractorsGT100K |
| Government Grants | 148500 | GovernmentGrants |
| All Other Contributions | 3834661 | AllOtherContributions |
| Noncash Contributions | 598576 | NoncashContributions |
| Total Contributions | 3983161 | TotalContributions |
Investment Income InvestmentIncome
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | 4161 | TotalRevenueColumn |
| Exclusion | $4,161 | ExclusionAmount |
Gross Amount Sales Assets GrossAmountSalesAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | 588660 | Securities |
Less Cost Oth Basis Sales Expenses LessCostOthBasisSalesExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | 598576 | Securities |
Gain Or Loss GainOrLoss
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | -9916 | Securities |
Net Gain Or Loss Investments NetGainOrLossInvestments
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | -9916 | TotalRevenueColumn |
| Related Or Exempt Function Income | -9916 | RelatedOrExemptFunctionIncome |
Total Revenue TotalRevenue
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | 3977406 | TotalRevenueColumn |
| Related Or Exempt Function Income | -9916 | RelatedOrExemptFunctionIncome |
| Unrelated Business Revenue | 0 | UnrelatedBusinessRevenue |
| Exclusion | $4,161 | ExclusionAmount |
Grants To Domestic Orgs GrantsToDomesticOrgs
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 3394263 | Total |
| Program Services | 3394263 | ProgramServices |
Comp Current Officers Directors CompCurrentOfficersDirectors
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 255165 | Total |
| Program Services | 58844 | ProgramServices |
| Management And General | 92172 | ManagementAndGeneral |
| Fundraising | 104149 | Fundraising |
Other Employee Benefits OtherEmployeeBenefits
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 50245 | Total |
| Program Services | 13208 | ProgramServices |
| Management And General | 21391 | ManagementAndGeneral |
| Fundraising | 15646 | Fundraising |
Fees For Services Management FeesForServicesManagement
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 4137 | Total |
| Management And General | 4137 | ManagementAndGeneral |
Fees For Services Legal FeesForServicesLegal
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 1952 | Total |
| Management And General | 1952 | ManagementAndGeneral |
Fees For Services Accounting FeesForServicesAccounting
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 34704 | Total |
| Management And General | 34704 | ManagementAndGeneral |
Fees For Services Lobbying FeesForServicesLobbying
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 38851 | Total |
| Fundraising | 38851 | Fundraising |
Fees For Services Other FeesForServicesOther
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 2200 | Total |
| Fundraising | 2200 | Fundraising |
Advertising Advertising
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 7609 | Total |
| Fundraising | 7609 | Fundraising |
Office Expenses OfficeExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 2346 | Total |
| Management And General | 2346 | ManagementAndGeneral |
Information Technology InformationTechnology
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 10501 | Total |
| Management And General | 2132 | ManagementAndGeneral |
| Fundraising | 8369 | Fundraising |
Occupancy Occupancy
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 24000 | Total |
| Management And General | 24000 | ManagementAndGeneral |
Travel Travel
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 8601 | Total |
| Program Services | 5160 | ProgramServices |
| Management And General | 3441 | ManagementAndGeneral |
Conferences Meetings ConferencesMeetings
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 20512 | Total |
| Program Services | 18339 | ProgramServices |
| Management And General | 2173 | ManagementAndGeneral |
Depreciation Depletion DepreciationDepletion
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 4051 | Total |
| Management And General | 4051 | ManagementAndGeneral |
Insurance Insurance
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 2383 | Total |
| Management And General | 2383 | ManagementAndGeneral |
Other Expenses OtherExpenses (5 entries)
| DescriptionDescription | TotalTotal | Program ServicesProgramServices | Management And GeneralManagementAndGeneral | FundraisingFundraising |
|---|---|---|---|---|
| Information and awarene | 57184 | 57184 | ||
| SAB/RC support honorari | 28470 | 28470 | ||
| Loss on abandonment of | 27101 | 27101 | ||
| Social network | 24300 | 24300 | ||
| Board and executive mee | 13126 | 13126 |
All Other Expenses AllOtherExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 70690 | Total |
| Program Services | 15321 | ProgramServices |
| Management And General | 18579 | ManagementAndGeneral |
| Fundraising | 36790 | Fundraising |
Total Functional Expenses TotalFunctionalExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 4082391 | Total |
| Program Services | 3590789 | ProgramServices |
| Management And General | 253688 | ManagementAndGeneral |
| Fundraising | 237914 | Fundraising |
Cash Non Interest Bearing CashNonInterestBearing
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 1093187 | BOY |
| EOY | 654165 | EOY |
Savings And Temp Cash Investments SavingsAndTempCashInvestments
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 1841227 | BOY |
| EOY | 2343857 | EOY |
Pledges And Grants Receivable PledgesAndGrantsReceivable
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 71822 | BOY |
| EOY | 15267 | EOY |
Accounts Receivable AccountsReceivable
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 22545 | BOY |
| EOY | 219843 | EOY |
Prepaid Expenses Deferred Charges PrepaidExpensesDeferredCharges
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 7861 | BOY |
| EOY | 3810 | EOY |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Buildings Equipment Basis | 28902 | LandBuildingsEquipmentBasis |
| Land Bldg Equipment Accum Deprec | 15088 | LandBldgEquipmentAccumDeprec |
Land Buildings Equipment Basis Net LandBuildingsEquipmentBasisNet
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 34194 | BOY |
| EOY | 13814 | EOY |
Intangible Assets IntangibleAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 465 | BOY |
| EOY | 386 | EOY |
Other Assets Total OtherAssetsTotal
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 21845 | BOY |
| EOY | 21998 | EOY |
Total Assets TotalAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 3093146 | BOY |
| EOY | 3273140 | EOY |
Accounts Payable Accrued Expenses AccountsPayableAccruedExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 23205 | BOY |
| EOY | 307585 | EOY |
Other Liabilities OtherLiabilities
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 11297 | BOY |
| EOY | 11352 | EOY |
Total Liabilities TotalLiabilities
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 34502 | BOY |
| EOY | 318937 | EOY |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Follow SFAS117 | X | FollowSFAS117 |
Unrestricted Net Assets UnrestrictedNetAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| EOY | 2938936 | EOY |
Temporarily Restricted Net Assets TemporarilyRestrictedNetAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| EOY | 15267 | EOY |
Total Net Assets Fund Balances TotalNetAssetsFundBalances
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 3058644 | BOY |
| EOY | 2954203 | EOY |
Total Liab Net Assets Fund Balances TotalLiabNetAssetsFundBalances
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 3093146 | BOY |
| EOY | 3273140 | EOY |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part XI | X | InfoInScheduleOPartXI |
| Reconcilation Revenue Expenses | -104985 | ReconcilationRevenueExpenses |
| Reconcilation Other Changes | 544 | ReconcilationOtherChanges |
| Method Of Accounting Accrual | X | MethodOfAccountingAccrual |
| Accountant Compile Or Review | 0 | AccountantCompileOrReview |
| FS Audited | 1 | FSAudited |
| Audit Committee | 1 | AuditCommittee |
| Financial Statement Separate | X | FinancialStatementSeparate |
| Federal Grant Audit Required | 0 | FederalGrantAuditRequired |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Publicly Supported Org170b1 Avi | X | PubliclySupportedOrg170b1Avi |
Gifts Grants Contrib Received170 GiftsGrantsContribReceived170
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | 3283332 | CurrentTaxYearMinus4Years |
| Current Tax Year Minus3 Years | 3560203 | CurrentTaxYearMinus3Years |
| Current Tax Year Minus2 Years | 3042089 | CurrentTaxYearMinus2Years |
| Current Tax Year Minus1 Year | 3339366 | CurrentTaxYearMinus1Year |
| Current Tax Year | 4039719 | CurrentTaxYear |
| Total | 17264709 | Total |
Total170 Total170
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | 3283332 | CurrentTaxYearMinus4Years |
| Current Tax Year Minus3 Years | 3560203 | CurrentTaxYearMinus3Years |
| Current Tax Year Minus2 Years | 3042089 | CurrentTaxYearMinus2Years |
| Current Tax Year Minus1 Year | 3339366 | CurrentTaxYearMinus1Year |
| Current Tax Year | 4039719 | CurrentTaxYear |
| Total | 17264709 | Total |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Amounts Subst Contributors Total | 7089876 | AmountsSubstContributorsTotal |
| Public Support Total170 | 10174833 | PublicSupportTotal170 |
Gross Investment Income170 GrossInvestmentIncome170
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | 23434 | CurrentTaxYearMinus4Years |
| Current Tax Year Minus3 Years | 97016 | CurrentTaxYearMinus3Years |
| Current Tax Year Minus2 Years | 74626 | CurrentTaxYearMinus2Years |
| Current Tax Year Minus1 Year | 20020 | CurrentTaxYearMinus1Year |
| Current Tax Year | -5755 | CurrentTaxYear |
| Total | 209341 | Total |
Other Income170 OtherIncome170
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus1 Year | -498 | CurrentTaxYearMinus1Year |
| Total | -498 | Total |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | 17473552 | TotalSupport |
| Public Support Pertcentage170 | 0.58230 | PublicSupportPertcentage170 |
| Public Support Pertcent Prior Year | 0.56180 | PublicSupportPertcentPriorYear |
| Thirty Three Percnt Tests CY170 | X | ThirtyThreePercntTestsCY170 |
Schedule B IRS990ScheduleB
Contributor Info ContributorInfo
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor Number | RESTRICTED | ContributorNumber |
Contributor Name Business ContributorNameBusiness
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor Address US ContributorAddressUS
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Aggregate Contributions | RESTRICTED | AggregateContributions |
Schedule C IRS990ScheduleC
| Field | Value | IRS element (for citing) |
|---|---|---|
| Volunteers | 0 | Volunteers |
| Paid Staff Or Management | 0 | PaidStaffOrManagement |
| Media Advertisements | 0 | MediaAdvertisements |
| Mailings Members | 0 | MailingsMembers |
| Publications Or Broadcast | 0 | PublicationsOrBroadcast |
| Grants Other Organizations | 0 | GrantsOtherOrganizations |
| Direct Contact Legislators | 1 | DirectContactLegislators |
| Direct Contact Legislators | $38,851 | DirectContactLegislatorsAmount |
| Rallies Demonstrations | 0 | RalliesDemonstrations |
| Other Activities | 0 | OtherActivities |
| Total Lobbying Expenditures IIB | 38851 | TotalLobbyingExpendituresIIB |
| Not Described In501c3 | 0 | NotDescribedIn501c3 |
Form990 Schedule C Part IV Form990ScheduleCPartIV
| Field | Value | IRS element (for citing) |
|---|---|---|
| Identifier | Explanation of Other Lobbying Activities: | Identifier |
| Return Reference | Part II-B, Line 1i: | ReturnReference |
| Explanation | A registered lobbyist contacted various Congressional legislators for the purpose of encouraging increased funding of Alzheimer's disease research. | Explanation |
Schedule D IRS990ScheduleD
Equipment Equipment
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | 9798 | OtherCostOrOtherBasis |
| Depreciation | 5820 | Depreciation |
| Book Value | 3978 | BookValue |
Other Land Buildings OtherLandBuildings
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | 19104 | OtherCostOrOtherBasis |
| Depreciation | 9268 | Depreciation |
| Book Value | 9836 | BookValue |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Of Book Value Land Buildings | 13814 | TotalOfBookValueLandBuildings |
Other Liabilities OtherLiabilities (2 entries)
| DescriptionDescription | AmountAmount |
|---|---|
| Accrued payroll | $9,776 |
| Accrued profit sharing contribution | $1,576 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Of Amounts | 11352 | TotalOfAmounts |
| Total Revenue | 3977406 | TotalRevenue |
| Total Expenses | 4082391 | TotalExpenses |
| Excess Or Deficit For Year | -104985 | ExcessOrDeficitForYear |
| Net Unrealized GL On Investments | 544 | NetUnrealizedGLOnInvestments |
| Total Adjustments | 544 | TotalAdjustments |
| Excess Or Deficit Per FS | -104441 | ExcessOrDeficitPerFS |
| Tot Revenue Etc Audited Fincl Stmt | 4064743 | TotRevenueEtcAuditedFinclStmt |
| Net Unrealized Gains Investments | 544 | NetUnrealizedGainsInvestments |
| Donated Srvc And Use Of Facilities | 30238 | DonatedSrvcAndUseOfFacilities |
| Other Revenues | 57500 | OtherRevenues |
| Revenue Not Rptd F990 | 88282 | RevenueNotRptdF990 |
| Revenue Subtotal | 3976461 | RevenueSubtotal |
| Other Revenues Not Included | 945 | OtherRevenuesNotIncluded |
| Revenue Not Rptd On Fin Stmt | 945 | RevenueNotRptdOnFinStmt |
| Total Revenue Per Form990 | 3977406 | TotalRevenuePerForm990 |
| Tot Expenses Etc Audited Fincl Stmt | 4112629 | TotExpensesEtcAuditedFinclStmt |
| Donated Services Use Of Facilities | 30238 | DonatedServicesUseOfFacilities |
| Expenses Not Rptd F990 | 30238 | ExpensesNotRptdF990 |
| Expenses Subtotal | 4082391 | ExpensesSubtotal |
| Expenses Not Rptd On Fin Stmt | 0 | ExpensesNotRptdOnFinStmt |
| Total Expenses Per Form990 | 4082391 | TotalExpensesPerForm990 |
Form990 Schedule D Part XIV Form990ScheduleDPartXIV (2 entries)
| IdentifierIdentifier | Return ReferenceReturnReference | ExplanationExplanation |
|---|---|---|
| Description of Uncertain Tax Positions Under FIN 48: | Part X: | Income Taxes - CAF was determined to be exempt from federal income tax under provisions of Section 501(c)(3) of the Internal Revenue Code of 1986 (IRC) and has been classified as an organization that is not a private foundation as defined in Section 509(a)(3) of the IRC. Accordingly, no provisions for federal or state income taxes are required. CAF is required to recognize the financial statement impact of a tax position when it is more likely than not that the position will be sustained upon examination. Any interest and penalties recognized associated with a tax position would be classified as current in CAF's financial statements. Currently, the tax years ended December 31, 2007, 2008, and 2009 are open and subject to examination by the Internal Revenue Service and the Massachusets Department of Revenue. However, CAF is not currently under audit nor has CAF been contacted by any of these jurisdictions. Based on the evaluation of CAF's tax positions, management believes all positions taken would be upheld under an examination. Therefore, no provision for the effects of uncertain tax positions has been recorded for the year ended December 31, 2010. |
| The adjustment on line 8 of Schedule D, Part XIV represents a reduction in pledges receivable from 2009 to 2010. |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | 0 | GrantRecordsMaintained |
| Subtotal Number Of Employees | 0 | SubtotalNumberOfEmployees |
| Cont Number Of Employees | 0 | ContNumberOfEmployees |
| Total Number Of Employees | 0 | TotalNumberOfEmployees |
| Subtotal Amount Spent | 0 | SubtotalAmountSpent |
| Cont Amount Spent | 0 | ContAmountSpent |
| Total Amount Spent | 0 | TotalAmountSpent |
Grants To Ind Outside US GrantsToIndOutsideUS
| Field | Value | IRS element (for citing) |
|---|---|---|
| Type Of Assistance | CAF funds the management and continued development of the revolutionary web-based database, AlzGene.org. | TypeOfAssistance |
| Region | BERLIN, BRANDENBURG, GERMANY | Region |
| Number Of Recipients | 1 | NumberOfRecipients |
| Amount Of Cash Grant | 122336 | AmountOfCashGrant |
| Manner Of Cash Disbursement | Check | MannerOfCashDisbursement |
| Amount Of Non Cash Assistance | 0 | AmountOfNonCashAssistance |
| Description Of Non Cash Assistance | None | DescriptionOfNonCashAssistance |
| Method Of Valuation | Project budget | MethodOfValuation |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Transfer To Foreign Corp | 0 | TransferToForeignCorp |
| Interest In Foreign Trust | 0 | InterestInForeignTrust |
| Own Foreign Corp | 0 | OwnForeignCorp |
| Passive Foreign Invest Co | 0 | PassiveForeignInvestCo |
| Foreign Partnership | 0 | ForeignPartnership |
| Boycott Countries | 0 | BoycottCountries |
Form990 Schedule F Part V Form990ScheduleFPartV
| Field | Value | IRS element (for citing) |
|---|---|---|
| Identifier | Explanation for Estimated Number of Recipients: | Identifier |
| Explanation | Schedule F, Part III, Col (c): Max Plank Institute for Molecular Genetics, Lars Bertrum, Project Manager | Explanation |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Records Maintained | 1 | RecordsMaintained |
Recipient Table RecipientTable (16 entries)
| Address Line1AddressUS/AddressLine1 | CityAddressUS/City | StateAddressUS/State | ZIP CodeAddressUS/ZIPCode | IRC SectionIRCSection | Amount Of Cash GrantAmountOfCashGrant | Purpose Of GrantPurposeOfGrant | Address Line2AddressUS/AddressLine2 |
|---|---|---|---|---|---|---|---|
| Massachusetts General Hospital MGH Aging and Research Unit | |||||||
| 114 16th Street | Charlestown | MA | 02129 | 501c3 | 1200000 | Continuation of Alzheimer's Genome Project | |
| Massachusetts General Hospital MGH Aging and Research Unit | |||||||
| 114 16th Street | Charlestown | MA | 02129 | 501c3 | 300000 | Abeta as an Anti-Microbial Agent | |
| Massachusetts General Hospital MGH Aging and Research Unit | |||||||
| 114 16th Street | Charlestown | MA | 02129 | 501c3 | 100000 | Design and Development of Novel ACAT Inhibitors for Alzheimer's DiseaseSpecificity and Mechanism of A-beta Oligomer Through Prior Protein | |
| Massachusetts General Hospital MGH Aging and Research Unit | |||||||
| 114 16th Street | Charlestown | MA | 02129 | 501c3 | 100000 | Curcumin Collaborative Project | |
| University of Pittsburgh | |||||||
| 3811 OHara Street | Pittsburgh | PA | 15213 | 501c3 | 300000 | Curcumin Collaborative Project | |
| The University of Chicago | |||||||
| 947 E 58th Street | Chicago | IL | 60637 | 501c3 | 100000 | Modulation of Abeta Deposition by Cell-Specific Mechanisms | |
| The University of Chicago | |||||||
| 947 E 58th Street | Chicago | IL | 60637 | 501c3 | 100000 | Exploring mechanisms of neuroserpin regulation in Alzheimer's disease | |
| University of San DiegoCA and MassGeneral Hospital | |||||||
| 9500 Gilman Drive Mailcode 0624 | La Jolla | CA | 92093 | 501c3 | 250000 | Novel Soluable Gamma-Secretase ModulatorsContinuation of Alzheimer's Genome Project | |
| Trustees of University of Pennsylvania | |||||||
| 3451 Walnut Street | Philadelphia | PA | 191046205 | 501c3 | 100000 | Passive Tau Immunotherapy for Treatment of Alzheimer's Disease | |
| Regents of University of Pennsylvania | |||||||
| 3451 Walnut Street | Philadelphia | PA | 191046205 | 501c3 | 63851 | Mouse Model for Non-Generic Alzheimer's Disease | |
| Mt Sinai School of Medicine Dept of Neurology | |||||||
| One Gustov L Levy Place Annenbeg | New York | NY | 10029 | 503c3 | 100000 | Brain Structure, Abeta Metabolism and Behavior in Mice Deficient in Diabetes and Alzheimer's Associated SorCS1 | 14-60 |
| Regents of University of California | |||||||
| Dept of Molecular Biology and | Irvine | CA | 926973900 | 501c3 | 100000 | NMDA Receptors | Chemistry |
| Washington University School of Medicine Dept of Neurology | |||||||
| 660 S Euclid Avenue Box 8018 | St Louis | MO | 63110 | 501c3 | 100000 | Anti-APOE AntibodiesAnti-APOE Antibodies | |
| Max Planck Institute for Molecular Genetics | |||||||
| Ihnestrasse 63 Room 2041 | Berlin | DE | 14195 | 501c3 | 122336 | Sustaining Support for the AlzGene | |
| University of Houston & University of Texas Health Science Center | |||||||
| 7000 Fannin Suite 600 | Houston | TX | 77030 | 501c3 | 40000 | Peak and Treat Approach to Diagnosis, Treatment and Monitoring of Alzheimer's Disease | |
| Washington University School of Medicine | |||||||
| 660 S Euclid Avenue Box 8018 | St Louis | MO | 63110 | 501c3 | 18100 | Microdialysis Supplement | |
Form990 Schedule I Part IV Form990ScheduleIPartIV
| Field | Value | IRS element (for citing) |
|---|---|---|
| Identifier | Procedure for Monitoring Grants in the U.S.: | Identifier |
| Return Reference | Part I, Line 2: | ReturnReference |
| Explanation | Schedule I, Part I, Line 2: 1. Cure Alzheimer's Fund (CAF) does not accept unsolicited proposals; all grant proposals are by invitation. 2. Each proposal is reviewed by: a. Chair of the CAF Research Consortium, a senior research scientist on the faculty of Harvard Medical School and Massachusetts General Hospital. If the proposal is approved by him, it goes to: b. The CAF Scientific Review Board, composed of five eminent research scientists at leading Alzheimer's research institutions in the United States. If that board approves the proposal, it then goes to: c. The Executive Committee of the CAF Board of Directors for final sign-off. 3. Once approved, a mid-year report is expected and is reviewed by the Chair of the Research Consortium. 4. At the end of the grant period (usually one year), a final report is submitted by the researcher and made available to the members of the Research Consortium for review and possible collaboration. 5. CAF is credited for support in any published papers resulting from the project. | Explanation |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Compensation Committee | X | CompensationCommittee |
| Written Employment Contract | X | WrittenEmploymentContract |
| Compensation Survey | X | CompensationSurvey |
| Board Or Committee Approval | X | BoardOrCommitteeApproval |
| Severance Payment | 0 | SeverancePayment |
| Supplemental Nonqual Retire Plan | 0 | SupplementalNonqualRetirePlan |
| Equity Based Comp Arrangement | 0 | EquityBasedCompArrangement |
| Comp Based On Revenue Of Filing Org | 0 | CompBasedOnRevenueOfFilingOrg |
| Comp Based On Revenue Related Orgs | 0 | CompBasedOnRevenueRelatedOrgs |
| Comp Based Net Earnings Filing Org | 0 | CompBasedNetEarningsFilingOrg |
| Comp Based Net Earnings Relate Orgs | 0 | CompBasedNetEarningsRelateOrgs |
| Any Non Fixed Payments | 0 | AnyNonFixedPayments |
| Initial Contract Exception | 0 | InitialContractException |
Form990 Schedule J Part II Form990ScheduleJPartII
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name Person | Timothy W Armour | NamePerson |
| Base Compensation Filing Org | 177053 | BaseCompensationFilingOrg |
| Comp Based On Related Orgs | 0 | CompBasedOnRelatedOrgs |
| Bonus Filing Org | 0 | BonusFilingOrg |
| Bonus Related Orgs | 0 | BonusRelatedOrgs |
| Other Compensation Filing Org | 0 | OtherCompensationFilingOrg |
| Other Compensation Related Orgs | 0 | OtherCompensationRelatedOrgs |
| Deferred Comp Filing Org | 0 | DeferredCompFilingOrg |
| Deferred Comp Related Orgs | 0 | DeferredCompRelatedOrgs |
| Nontaxable Benefits Filing Org | 0 | NontaxableBenefitsFilingOrg |
| Nontaxable Benefits Related Orgs | 0 | NontaxableBenefitsRelatedOrgs |
| Total Compensation Filing Org | 177053 | TotalCompensationFilingOrg |
| Total Compensation Related Orgs | 0 | TotalCompensationRelatedOrgs |
| Comp Report Prior990 Filing Org | 0 | CompReportPrior990FilingOrg |
| Comp Report Prior990 Related Orgs | 0 | CompReportPrior990RelatedOrgs |
Schedule M IRS990ScheduleM
Securities Publicly Traded SecuritiesPubliclyTraded
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | X | NonCashCheckbox |
| Number Of Contributions | 11 | NumberOfContributions |
| Noncash Contribs Rptd F990 | 598576 | NoncashContribsRptdF990 |
| Method Of Determining Revenues | average high and low | MethodOfDeterminingRevenues |
Other Non Cash Contributions Table OtherNonCashContributionsTable
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | X | NonCashCheckbox |
| Description | Services | Description |
| Number Of Contributions | 1 | NumberOfContributions |
| Noncash Contribs Rptd F990 | 30238 | NoncashContribsRptdF990 |
| Method Of Determining Revenues | Invoice amount | MethodOfDeterminingRevenues |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Any Property That Must Be Held | 0 | AnyPropertyThatMustBeHeld |
| Review Process Unusual NC Gifts | 0 | ReviewProcessUnusualNCGifts |
| Third Parties Used | 1 | ThirdPartiesUsed |
Form990 Schedule M Part II Form990ScheduleMPartII
| Field | Value | IRS element (for citing) |
|---|---|---|
| Identifier | Third Party Use: | Identifier |
| Return Reference | Part I, Line 32b: | ReturnReference |
| Explanation | The organization uses a commercial broker to process and sell publicly traded securities. | Explanation |
Schedule O IRS990ScheduleO
General Explanation GeneralExplanation (6 entries)
| IdentifierIdentifier | ExplanationExplanation | Return ReferenceReturnReference |
|---|---|---|
| Form 990, Part VI, Section A, line 2 | Jeffrey Morby and Jacqueline Morby are both directors and marriage partners. | |
| Form 990, Part VI, Section B, line 11 | Jeffrey Morby and Phyllis Morby are both directors and marriage partners. | |
| The President regularly and consistently monitors compliance with conflicts of interest by requesting that all officers, directors, and founders sign the annual statement disclosing all interests that might conflict with any interest of the organization. | Form 990, Part VI, Section B, line 12c | |
| Performance review and comparability data are submitted annually to executive committee for compensation approval for the President and all other employees. | Form 990, Part VI, Section B, line 15 | |
| The governing documents, conflict of interest policy and financial statements are made available on the organization's website and upon request. | Form 990, Part VI, Section C, line 19 | |
| Changes in Net Assets or Fund Balances: | Net unrealized gains on investments: 544. | Form 990, Part XI, line 5: |
Comments